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CancerAbstract Objective: The aim of this study was to evaluate the clinical performance of 3D
tomosynthesis in comparison with Full Field Digital Mammography (FFDM) in the detection
and diagnosis of breast lesions.
Material and methods: 132 patients underwent standard digital mammography and tomosynthesis
and the likelihood of malignancy was categorized according to (ACR) BI-RADS.
Results: Tomosynthesis images had significantly increased the number of cases with BI-RAD 1 or 2
(normal/benign) to 62 (42.7%) compared to 39 (26.8%) at mammogram (p< 0.005). Tomosynthe-
sis helped also in more clarification of benign characters. Tomosynthesis images had significantly
decreased the number of indeterminate/suspicious lesions (BI-RADS 3 and 4) from 90 (62%) cases
to 39 (26.8%) (p< 0.005). In a total of 40 lesions (27.5%) assigned to BI-RADS 5 at tomosynthe-
sis, the tomosynthesis showed better performance in assessment of tumor extension and higher level
in detection of clusters of micro-calcifications.
The accuracy, specificity, sensitivity and positive and negative predictive values (%) of mammogra-
phy alone versus when combined with the tomosynthesis were as follows: 59.3, 62.8, 55.2, 56 and 62
versus 91.7, 92.3, 91, 91, and 92.3 respectively (Table 4).
Tomosynthesis significantly improved the detection of the breast lesions on mammography images
especially in the dense breast with significantly higher accurate BI-RADS scoring (P value <0.005).
Conclusion: Breast tomosynthesis is a promising technology that offers improved diagnostic and
screening accuracy, fewer recalls as well as 3D lesion localization. Lesion conspicuity is improved
using DBT compared with FFDM with a more confidence in making clinical decisions.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).yahoo.
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Digital mammography has become an accepted standard of
care in screening and diagnosis of breast cancer; however, it
has some limitations that are mainly attributed to the
superimposition of normal breast structures in the path of
the X-ray beam that diminishing the positive predictive value
and specificity of the examination (1–4).
Breast tomosynthesis is a modality that acquires images of
a breast at multiple angles during a short scan. The individual
images are then reconstructed into a series of thin, high-
resolution slices so eliminating the problem of overlapping
structures in the breast as well thereby enhancing margin
visibility, particularly in dense breasts (5–9).
The aim of this study was to evaluate the clinical
performance of 3D tomosynthesis in comparison with Full
Field Digital Mammography (FFDM) in the detection and
diagnosis of breast lesions.
2. Material and methods
The study protocol was approved by the Institutional Hospital
Ethical Committee. All patients provided informed consent.
Study was performed during the period of June 2013 to March
2015 and included 132 consenting women, showing at least one
breast lesion discovered by standard digital mammography
and/or ultrasound (US). They underwent standard digital
mammography in two views the cranio-caudal (CC) and
medio-lateral oblique (MLO) views and tomosynthesis in both
views (MLO and CC) of both breasts.
Mammography examination: FFDM and 3D tomosynthe-
sis examination was done by GE’s SenoClaire 3D breast
tomosynthesis system. During a tomosynthesis scan, multiple
projections (10–14) of low-dose exposure the breast areTable 1 Breast lesion visibility at FFDM alone and
tomosynthesis.
Mammography Tomosynthesis Total
Yes No
Yes 106 0 106
No 32 7 39
Total 138 7 145
Table 2 BI-RADS score at mammography and tomosynthesis.
Mammography
BI-RADS
Tomosynthesis BI-RADS
1 2 3
1 3 12 2
2 3 10 2
3 8 20 8
4 2 4 2
5 0 0 0
6 0 0 0
Total 16 46 14acquired at different angles while the X-ray tube moves in an
arc fashion across the breast. Then reconstruction into one
mm-thickness slices was performed off-line (i.e., at a different
time from the image acquisition) to gain about 60–90 that can
be further reconstructed to a three dimensional image. Images
are displayed in slice or cine loop mode on dedicated high res-
olution work stations. The monitors were calibrated to the
DICOM Gray scale Standard Display function. The radiolo-
gists were able to pan, zoom and alter the window level of
the images.
A complementary ultrasound examination was done for all
patients using Aplio XG device (Toshiba, Japan) using
6–10 MHz high frequency probes.
The reviewers categorized the likelihood of malignancy
according to the American College of Radiology (ACR) Breast
Imaging Data and Reporting System (BI-RADS) categories
(15) in each of FFDM and breast tomosynthesis by radiolo-
gists in a consensus reading.
Breast density was assigned according to the BI-RADS edi-
tion (2013) to a, b, c and d-categories (a: the breast is almost
entirely fatty, b: scattered areas of fibroglandular density,
c: the breast is heterogeneously dense, and d: the breast is
extremely dense (10)).
Qualitative items, such as mass shape, margins, density,
architectural distortion, and calcifications were also recorded.
The radiologists were blinded to the findings of other
modalities, to clinical reports, patient history, histology, and
clinical follow-up. If the two readers could not reach consen-
sus, datasets were forwarded to a third reviewer.
The golden standard was histology for lesions that had
undergone breast biopsy (all of which were classified as malig-
nant lesions (n= 67), plus a small proportion of those consid-
ered benign (n= 21) and fine-needle aspiration cytology
(FNAC), whenever available, and 1-year follow-up for benign
classified lesions. A one year stable lesion was considered of
benign nature.
2.1. Statistical analysis
The data obtained from Full Field Digital Mammography and
Digital Tomosynthesis were tabulated and compared as
regards detection and diagnosis. Each modality was individu-
ally assessed using the Pearson Chi Square tests. The accuracy,
sensitivity, specificity and positive and negative predictive val-
ues of either modality were also calculated. P value <0.05 is
considered to be significant.4 5 6 Total
1 0 0 18
4 2 0 21
3 2 0 41
17 24 0 49
0 12 0 12
0 0 4 4
25 40 4 149
Fig. 1 Full field digital mammography (FFDM) in MLO (a) and CC (b) views showing left retro-areolar mass (yellow arrow).
Tomosynthesis in MLO (c) and CC (d) views showed its well-defined margin (yellow arrow) and revealed a smaller adjacent one (red
arrow). Final diagnosis is two simple cysts.
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Fig. 2 FFDM in MLO (a) and CC (b) views revealed three ill-defined nodules (yellow arrows) seen at left breast upper outer quadrant
(UOQ). Tomosynthesis in MLO (c) and CC (d) views confirmed the presence of only two masses, the first is partly ill-defined (yellow
arrow) and other is ill-defined finely speculated nodule (red arrow). Final diagnosis: two malignant masses (NB: multiple axillary lymph
nodes).
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Fig. 3 FFDM in MLO (a) and cc (b) views showed asymmetric density noted at lower half of right breast, seen only in the MLO view
(yellow arrow) while Tomosynthesis in MLO (c) and CC (d) revealed a well-defined nodule (yellow arrow). Final diagnosis:
Fibroadenoma.
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This study included 132 patients; average age of 59 years
(range 34–74 years old). The dataset according to the final
diagnosis included 145 breasts, 67 of them were malignant
and 78 were with benign lesions. The analysis was performed
per breast, which means that only one finding per breast wascounted i.e. the finding with the highest BI-RADS score was
taken for the analysis in all cases.
Out of the total 145 breast lesions, 67 were cancers of which
34 (50.8%) were invasive ductal cancers (IDC), 17 (25.4%)
invasive lobular cancers (ILC), 7 (10.4%) IDC with ductal car-
cinoma in situ (DCIS), 3 (4.4%) tubular cancers, 2(3%) asso-
ciated with DCIS, 2 (3%) DCIS alone, and 2 (3%) intracystic
Fig. 4 FFDM in MLO (a) and CC (b) views revealed dense breast with no definite masses detected while tomosynthesis in MLO (c) and
CC (d) views revealed right breast UOQ deeply seated well defined mass, (yellow arrow). Final diagnosis: Fibroadenoma.
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4.5–45 mm). The remaining lesions (n= 78) were benign
(Table 1).
Initial BI-RADS score was assigned to each mammogram,
then re-evaluation and re-adjustment of the score were done
after reviewing the tomosynthesis images. The BI-RADS score
thus was ranked higher (upgraded), ranked lower (down-
graded) or remained the same (Table 2).
Breast density was assigned according to the BI-RADS
edition (2013) to a, b, c and d-categories. Categories c
and d were assigned to 51 (35.1%) and 33 (27.7%)
respectively.
Tomosynthesis images had significantly increased the
number of cases with BI-RAD 1 or 2 (normal/benign) to 62
(42.7%) compared to 39 (26.8%) at mammogram
(p< 0.005). Tomosynthesis helped also in more clarification
of benign characters such as the well definition of the mass
margin, typical benign radiolucent halo as well as central fat
density thus allowing more confident diagnosis of benignity
(Figs. 1–3)).
Tomosynthesis images had significantly decreased the num-
ber of indeterminate/suspicious lesions (BI-RADS 3 and 4)
from 90 (62%) cases to 39 (26.8%) (p< 0.005) by supporting
either a benign or a malignant diagnosis, and the tomosynthe-
sis mammogram is as follows: 24 was upgraded to BI-RAD 5,
while 36 mammograms were downgraded to benign score
(Figs. 4 and 5).
In a total of 40 lesions (27.5%) assigned to BI-RADS 5 at
tomosynthesis, the tomosynthesis showed better performancein assessment of tumor extension and higher level in detection
of clusters of micro-calcifications (Fig. 6).
We had six mammograms that were scored as benign at
tomosynthesis (False negative). It included five small breast
lesions that were embedded in dense heterogeneous breast
parenchymal tissue and were hardly visible on US as a suspi-
cious mass and one case of occult malignancy, a low-grade
ductal carcinoma in situ (DCIS) arising in a papilloma that
was detected by focal enhancement at contrast-enhanced
MRI (Table 3).
On the other hand we had 6 false positive tomosynthesis
results (one granulomatous mastitis, 2 benign precancerous
lesions, one radial scar, and two cases of post surgical fat
necrosis).
The accuracy, specificity, sensitivity and positive and nega-
tive predictive values (%) of mammography alone versus when
combined with the tomosynthesis were as follows: 59.3, 62.8,
55.2, 56 and 62 versus 91.7, 92.3, 91, 91, and 92.3 respectively
(Table 4).
Tomosynthesis significantly improved the detection of the
breast lesions on mammography images especially in the dense
breast with significantly higher accurate BI-RADS scoring
(P value <0.005) (Fig. 7).4. Discussion
Breast tomosynthesis is a three-dimensional challenging
imaging technology that obtains multiple angles scanning of
Fig. 5 FFDM in MLO (a) revealed asymmetric density in upper half of left breast (yellow arrow), not detected in CC view (b).
Tomosynthesis in MLO view (c) revealed focal increased density with no underlying masses. Final diagnosis was glandular tissue
condensation.
Potential impact of tomosynthesis 357a stationary compressed breast with reconstruction of resulted
images into a series of thin high-resolution slices so greatly
reducing or eliminating the anatomical noise problems caused
by tissue overlap in two-dimensional mammography imaging
(11–14).
Several studies considered that the tomosynthesis has a
potential additional value in both screening and diagnosis ofbreast lesions with more accurate evaluation of lesions as well
as a higher sensitivity and specificity for breast cancer detec-
tion than digital mammography (16–23).
In a study carried out by Bernardi et al. (24), they evaluated
the effect of integrating 3D mammography with tomosynthesis
in breast screening on 158 consecutive recalls, and they
showed that combined 2D + 3D mammography is more
Fig. 6 FFDMMLO (a) and CC (b) views revealed left breast UOQ cluster of micro-calcifications (yellow arrow). Tomosynthesis MLO
(c) and CC (d) views confirmed the presence of micro-calcification cluster and excluded any underlying masses or distortion. It was stable
at follow-up.
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Table 3 Correct diagnosis of malignant breast lesions at
mammography and tomosynthesis.
True +ve False ve True ve False +ve
Tomosynthesis 61 6 72 6
Mammography 37 30 49 29
Table 4 Accuracy, specificity, sensitivity and positive and
negative predictive values (%) of mammography alone versus
when combined with the tomosynthesis.
Mammography Tomosynthesis
Accuracy (%) 59.3 91.7
Specificity (%) 62.8 92.3
Sensitivity (%) 55.2 91
Positive predictive values (%) 56 91
Negative predictive values (%) 62 92.3
Potential impact of tomosynthesis 359time-consuming than 2D mammography but it enhanced the
accuracy in cancer detection and reduced recall rate.
In addition, Noroozian et al. (9) issued a study to compare
the breast mass characterization using Digital Breast
Tomosynthesis (DBT) and mammographic spot views (MSV)
in 67 masses (30 malignant, 37 benign). They found that the
mean mass visibility ratings were slightly better with DBT than
with MSV with characterization of seven additional malignant
masses as BI-RADS 4 or 5 with DBT than with MSV.
In the report of Tingberg et al. (25), they reviewed digital
breast tomosynthesis and FFDM examinations in over 2000
women and showed higher sensitivity of BT in comparison
with single-view and 2-view digital mammography in the detec-
tion of breast cancer (p< 0.01).
In the current work, we also noticed that tomosynthesis had
a higher capability to detect breast lesions (138 lesions, 95%)
in comparison with mammogram (n= 106, 73%). Also a
notable improvement of malignant lesions detection by
tomosynthesis is achieved as of 67 lesions that proved to be
malignant, and tomosynthesis had correctly diagnosed 61
lesions (91%) while the estimation was lower by mammogra-
phy alone (37 lesions, 55.2%).
The current study included 84 lesions (57.9%) with dense
parenchymal texture (category c and d), in which we had five
lesions that showed false negative result at tomosynthesis, that
were small breast lesions that embedded in dense heteroge-
neous breast parenchymal tissue and that were not associated
with architectural distortion. it was shown at breast US and
confirmed by biopsies.
These results are also consistent with those achieved by
Skaane et al. (26) who carried out a study for 129 women
and showed that there were higher conspicuity scores for
tomosynthesis compared to conventional 2D for cancers
presenting.
In addition, this is in agreement with results of Poplack
et al. (1) who studied the impact of using DBT in 99 digital
screening recalls for 98 women with abnormal digital screening
mammography. They found that DBT image quality wasequivalent (n= 51) or superior (n= 37) to diagnostic
mammography in 89% (88/99). Thus they concluded that
DBT has the potential to decrease the recall rate by 40%
(37/92) when used adjunctively with digital screening
mammography.
Andersson et al. (12) compared the visibility of breast can-
cer in one-view digital breast tomosynthesis versus one- or
two-view Full-Field Digital Mammography (FFDM). They
reported a statistically significant upgrade rate of BI-RADS
assessments as they found that the cancer visibility on digital
breast tomosynthesis was greater in more than 50% of lesions
(22/40) compared with single-view FFDM.
Similar results were confirmed in the current work, as
tomosynthesis images significantly increased the number of
cases with BI-RADS 1 or 2 (normal/benign) to 62 (42.8%)
compared to 39 (26.9%) at mammogram. This can be
attributed to the fact that tomosynthesis helped in more
clarification of benign characters such as the well definition
of the mass margin, typical benign radiolucent halo and
central fat density thus allowing more confident diagnosis of
benignity.
In addition, tomosynthesis images significantly decreased
the number of indeterminate/suspicious lesions (BI-RADS 3
and 4) from 90 lesions (62%) to 39 (26.9%) (P< 0.005), by
supporting either a benign or a malignant diagnosis as follows:
24 mammograms were upgraded to BI-RAD 5, while 36 mam-
mograms were downgraded to benign score.
In a total of 40 lesions (27.6%) assigned to BI-RADS 5 at
tomosynthesis, tomosynthesis showed better performance in
assessment of tumor extension and higher level in detection
of clusters of micro-calcifications.
These results match also with the results of Gur et al. (27)
who analyzed a previously reported study of eight experienced
radiologists who interpreted 125 examinations, 35 of them
with verified cancers. On comparison of using a combined
FFDM and digital breast tomosynthesis to the FFDM alone,
about 16% improvement in performance was achieved (95%
CI, 7%–26%; p< 0.01).
In addition, this agrees with the study of Hakim et al. (11),
who reviewed the imaging studies, including FFDM, addi-
tional diagnostic views, and digital breast tomosynthesis of
25 women with known masses. Combined FFDM and digital
breast tomosynthesis were shown to be better for diagnosis
in 50% (50/100) of the BI-RADS ratings compared with
FFDM alone and additional views.
In the current study, tomosynthesis significantly enhanced
the cancer detection rate and showed a higher capability of
correct categorization of lesion into a benign or malignant
entity as it showed an accuracy of 91.7% compared to only
59.3% in mammography alone. This was associated with the
enhancement of the sensitivity to 91% compared with 55.2%
for mammography alone. Also, tomosynthesis images had
increased the specificity, positive and negative predictive values
(%) from 62.8, 56 and 62 to 92.3, 91 and 92.3 for mammogram
respectively.
The present study had some limitations as follows: (a) the
number of malignant tumors and benign lesions is limited,
(b) the lack of compressions or magnification that may
improve the diagnostic accuracy of the two-view FFDM,
and (c) non-screening methods as most of the patients present
with diagnosed breast pathology.
Fig. 7 FFDM CC view (a) revealed partially obscured nodule in lower half of right breast (white line) that suspecting malignancy while
Tomosynthesis CC view (b) showed the previously mentioned nodule be well defined (yellow arrow) and revealed another well-defined
nodule at retro-areolar region (red arrow). Final diagnosis: Fibroadenomata.
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Potential impact of tomosynthesis 3615. Conclusion
Breast tomosynthesis is a promising technology that offers
improved diagnostic and screening accuracy, fewer recalls as
well as 3D lesion localization. Lesion conspicuity is improved
using DBT compared with FFDM with a more confidence in
making clinical decisions.
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